ArticleEBioMedicine2024

GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort.

David Pellerin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.